BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24612940)

  • 1. Effects of Seijo-bofu-to, a traditional Japanese herbal medicine containing furanocoumarin derivatives, on the drug-metabolizing enzyme activities in healthy male volunteers.
    Saruwatari J; Takashima A; Yoshida K; Soraoka H; Ding TB; Uchiyashiki Y; Tsuda Y; Imamura M; Oniki K; Miyata K; Nakagawa K
    Basic Clin Pharmacol Toxicol; 2014 Oct; 115(4):360-5. PubMed ID: 24612940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A herbal-drug interaction study of keishi-bukuryo-gan, a traditional herbal preparation used for menopausal symptoms, in healthy female volunteers.
    Saruwatari J; Takaishi C; Yoshida K; Takashima A; Fujimura Y; Umemoto Y; Abe T; Kitamado M; Shimomasuda M; Muramoto Y; Nakagawa K
    J Pharm Pharmacol; 2012 May; 64(5):670-6. PubMed ID: 22471362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Yokukansan, a Traditional Herbal Preparation Used for the Behavioral and Psychological Symptoms of Dementia, on the Drug-Metabolizing Enzyme Activities in Healthy Male Volunteers.
    Soraoka H; Oniki K; Matsuda K; Ono T; Taharazako K; Uchiyashiki Y; Kamihashi R; Kita A; Takashima A; Nakagawa K; Yasui-Furukori N; Kadowaki D; Miyata K; Saruwatari J
    Biol Pharm Bull; 2016; 39(9):1468-74. PubMed ID: 27582327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of Shoseiryuto, a traditional Japanese medicine, on cytochrome P450s, N-acetyltransferase 2 and xanthine oxidase, in extensive or intermediate metabolizers of CYP2D6.
    Nakao M; Muramoto Y; Hisadome M; Yamano N; Shoji M; Fukushima Y; Saruwatari J; Nakagawa K
    Eur J Clin Pharmacol; 2007 Apr; 63(4):345-53. PubMed ID: 17297618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail".
    Streetman DS; Bleakley JF; Kim JS; Nafziger AN; Leeder JS; Gaedigk A; Gotschall R; Kearns GL; Bertino JS
    Clin Pharmacol Ther; 2000 Oct; 68(4):375-83. PubMed ID: 11061577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of St John's wort on the activities of CYP1A2, CYP3A4, CYP2D6, N-acetyltransferase 2, and xanthine oxidase in healthy males and females.
    Wenk M; Todesco L; Krähenbühl S
    Br J Clin Pharmacol; 2004 Apr; 57(4):495-9. PubMed ID: 15025748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in-vivo effect of bakumondo-to (TJ-29), a traditional Japanese medicine used for treatment of chronic airway disease, on cytochrome P450 1A2, xanthine oxidase and N-acetyltransferase 2 activity in man.
    Saruwatari J; Hisaeda S; Higa Y; Tomiyasu Y; Nakagawa K; Ishizaki T
    J Pharm Pharmacol; 2004 Sep; 56(9):1171-7. PubMed ID: 15324486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in-vivo effects of sho-saiko-to, a traditional Chinese herbal medicine, on two cytochrome P450 enzymes (1A2 and 3A) and xanthine oxidase in man.
    Saruwatari J; Nakagawa K; Shindo J; Nachi S; Echizen H; Ishizaki T
    J Pharm Pharmacol; 2003 Nov; 55(11):1553-9. PubMed ID: 14713367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activities of cytochrome P450 1A2, N-acetyltransferase 2, xanthine oxidase, and cytochrome P450 2D6 are unaltered in children with cystic fibrosis.
    Kennedy MJ; Scripture CD; Kashuba AD; Scott CS; Gaedigk A; Kearns GL
    Clin Pharmacol Ther; 2004 Mar; 75(3):163-71. PubMed ID: 15001967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maribavir pharmacokinetics and the effects of multiple-dose maribavir on cytochrome P450 (CYP) 1A2, CYP 2C9, CYP 2C19, CYP 2D6, CYP 3A, N-acetyltransferase-2, and xanthine oxidase activities in healthy adults.
    Ma JD; Nafziger AN; Villano SA; Gaedigk A; Bertino JS
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1130-5. PubMed ID: 16569820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous action of the flavonoid quercetin on cytochrome P450 (CYP) 1A2, CYP2A6, N-acetyltransferase and xanthine oxidase activity in healthy volunteers.
    Chen Y; Xiao P; Ou-Yang DS; Fan L; Guo D; Wang YN; Han Y; Tu JH; Zhou G; Huang YF; Zhou HH
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):828-33. PubMed ID: 19215233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Angelicae tenuissima radix, Angelicae dahuricae radix and Scutellariae radix extracts on cytochrome P450 activities in healthy volunteers.
    Yi S; Cho JY; Lim KS; Kim KP; Kim J; Kim BH; Hong JH; Jang IJ; Shin SG; Yu KS
    Basic Clin Pharmacol Toxicol; 2009 Oct; 105(4):249-56. PubMed ID: 19422358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined phenotypic assessment of cytochrome p450 1A2, 2C9, 2C19, 2D6, and 3A, N-acetyltransferase-2, and xanthine oxidase activities with the "Cooperstown 5+1 cocktail".
    Chainuvati S; Nafziger AN; Leeder JS; Gaedigk A; Kearns GL; Sellers E; Zhang Y; Kashuba AD; Rowland E; Bertino JS
    Clin Pharmacol Ther; 2003 Nov; 74(5):437-47. PubMed ID: 14586384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability in drug metabolizing enzyme activity in HIV-infected patients.
    Jones AE; Brown KC; Werner RE; Gotzkowsky K; Gaedigk A; Blake M; Hein DW; van der Horst C; Kashuba AD
    Eur J Clin Pharmacol; 2010 May; 66(5):475-85. PubMed ID: 20084375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activities.
    Fuchs P; Haefeli WE; Ledermann HR; Wenk M
    Eur J Clin Pharmacol; 1999 Jan; 54(11):869-76. PubMed ID: 10027663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A population phenotyping study of three drug-metabolizing enzymes in Kyushu, Japan, with use of the caffeine test.
    Saruwatari J; Nakagawa K; Shindo J; Tajiri T; Fujieda M; Yamazaki H; Kamataki T; Ishizaki T
    Clin Pharmacol Ther; 2002 Aug; 72(2):200-8. PubMed ID: 12189367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drinking Ethanol Has Few Acute Effects on CYP2C9, CYP2C19, NAT2, and P-Glycoprotein Activities but Somewhat Inhibits CYP1A2, CYP2D6, and Intestinal CYP3A: So What?
    Gazzaz M; Kinzig M; Schaeffeler E; Jübner M; Hsin CH; Li X; Taubert M; Trueck C; Iltgen-Breburda J; Kraus D; Queckenberg C; Stoffel M; Schwab M; Sörgel F; Fuhr U
    Clin Pharmacol Ther; 2018 Dec; 104(6):1249-1259. PubMed ID: 29633238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary effects of Sideritis scardica "mountain tea" on human in vivo activities of xenobiotic metabolizing enzymes in healthy subjects.
    Begas E; Kilindris T; Kouvaras E; Tsioutsioumi A; Kouretas D; Asprodini EK
    Food Chem Toxicol; 2018 Dec; 122():38-48. PubMed ID: 30266316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fluvoxamine therapy on the activities of CYP1A2, CYP2D6, and CYP3A as determined by phenotyping.
    Kashuba AD; Nafziger AN; Kearns GL; Leeder JS; Gotschall R; Rocci ML; Kulawy RW; Beck DJ; Bertino JS
    Clin Pharmacol Ther; 1998 Sep; 64(3):257-68. PubMed ID: 9757149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six-month, prospective, longitudinal, open-label caffeine and dextromethorphan phenotyping study in children with growth hormone deficiency receiving recombinant human growth hormone replacement.
    Kennedy MJ; Davis DA; Smith N; Gaedigk A; Pearce RE; Kearns GL
    Clin Ther; 2008 Sep; 30(9):1687-99. PubMed ID: 18840375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.